Back to All

Laboratories hold the key to success for patient care in Precision Medicine

19 February, 2021

At Diaceutics, we have known for a long time that Laboratories’ role is crucial to the timely application of innovations in Precision Medicine. That is why Diaceutics launched DXRX-The world’s first Diagnostic Network® for Precision Medicine around laboratories’ role1 to deliver on the right drug, to the right patient, at the right time.

This decision is the result of Diaceutics’ engagement with laboratories at the local, regional and global level, from the moment the first targeted therapy was commercialized, to Diaceutics being involved on every Precision Medicine ever brought to market2.

This decades-long relationship has resulted in the growth of a broad laboratory network, which has generated extensive data to provide the necessary insights to support the type of strategy needed, when introducing an innovative therapeutic into market. All to contribute to improve on patient outcomes.   

For laboratories, this type of engagement with Diaceutics has provided them with the opportunity to interact with their data in a new and dynamic way. Through benchmarking reports at the end of each project, labs have the opportunity to see in a safe manner, how they perform against other labs. Additionally, in the reports, Diaceutics captures guidelines at country, regional and global level, helping shape understanding for each lab as to where they are in a patient’s testing journey and whether action is required to improve on their position to deliver on vital, innovative care.

The power of that network effect through data3, creates a bigger picture which allows for labs to maneuver, based on facts, as to how their testing practices relate, to the actual testing needs of patients and physicians relying on them.

With this level of awareness, labs are prepared to act swiftly to, for example, ensure that they are included earlier in the patient testing journey, or even anticipate to upcoming testing needs because of new diagnostic reliant therapeutics coming into guidelines.

Register here to learn more about collaborations like the benchmark reports and joining this vibrant Precision Medicine network.

We are committed to the accelerated and quality-driven delivery of diagnostic reliant innovation to get every patient the treatment they deserve.


  1. DXRX For Labs - Diaceutics
  2. DXRX - The Diagnostic Network® (
  3. DXRX Data - Diaceutics


About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane

Tel: +44 (0)20 3405 0205 or [email protected]

Caroline Forde
Robyn Fisher
Kieran Breheny